Synthesis of a TNF inhibitor, flurbiprofen and an i-Pr analogue in enantioenriched forms by copper-catalyzed propargylic substitution with Grignard reagents.
Org Biomol Chem
; 19(45): 9906-9909, 2021 11 25.
Article
em En
| MEDLINE
| ID: mdl-34734958
The copper-catalyzed substitution reaction of diethyl phosphate derived from TMSCîCCH(OH)CH2CH2OTBDPS with 3-c-C5H9-4-MeOC6H3MgBr, followed by several transformations, afforded a tumor necrosis factor inhibitor possessing a Ph-acetylene moiety. The inhibitor was also synthesized from phenylacetylene phosphate PhCîCCH(OP(O)(OEt)2)CH2CH2OTBDPS. Furthermore, the substitution of phosphates derived from TMSCîCCH(OH)CH3 and TMSCîCCH(OH)-i-Pr with 3-F-4-PhC6H3MgBr gave the corresponding substitution products, which were transformed to flurbiprofen and its i-Pr analogue, respectively. The copper-catalyzed substitutions in these syntheses proceeded in a regio- and stereoselective manner.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Flurbiprofeno
/
Fator de Necrose Tumoral alfa
/
Cobre
/
Propanóis
/
Alcinos
/
Indicadores e Reagentes
Idioma:
En
Ano de publicação:
2021
Tipo de documento:
Article